Lynn O'brien, MSW | |
2515 N 124th St, Suite 101, Brookfield, WI 53005-4675 | |
(262) 641-4347 | |
(262) 641-4350 |
Full Name | Lynn O'brien |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 2515 N 124th St, Brookfield, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225127608 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 163-123 (Wisconsin) | Primary |
106H00000X | Marriage & Family Therapist | 688-124 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lynn O'brien, MSW 2515 N 124th St, Suite 101, Brookfield, WI 53005-4675 Ph: (262) 641-4347 | Lynn O'brien, MSW 2515 N 124th St, Suite 101, Brookfield, WI 53005-4675 Ph: (262) 641-4347 |
News Archive
A state-of-the-art engineering approach toward improving the neutralizing activity of a cross-reactive nanobody, previously generated against the original SARS virus, showed it can be an attractive and viable option against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study is published in the journal Advanced Therapeutics.
Many adults are dependent on the caffeine in their morning coffee to get them going. But what about kids? Children who regularly drink soda, iced tea and other caffeine-containing beverages and foods may be getting too much. Find out how caffeine can be bad for your kids (and you) - and how much is too much.
Exelixis, Inc. today announced preliminary results from BRIM7, an ongoing Phase Ib trial conducted by Roche and Genentech, Exelixis' collaborator and a member of the Roche Group, of the BRAF inhibitor (BRAFi) vemurafenib in combination with the MEK inhibitor GDC-0973 in patients with locally advanced/unresectable or metastatic melanoma carrying a BRAFV600 mutation.
A new study of hospital deaths in the United States, published today in JAMA Network Open, is the most comprehensive look yet at changes in hospital mortality during the pandemic.
› Verified 4 days ago